Results 191 to 200 of about 3,900,144 (339)

Electrochemical simulation of psychotropic drug metabolism compared to <i>in vivo</i> processes using liquid chromatography and mass spectrometry. [PDF]

Front Pharmacol
Jerszyńska P, Szultka-Młyńska M.
europepmc   +1 more source

Lifetime Incidence of Treated Mental Health Disorders and Psychotropic Drug Prescriptions and Associated Socioeconomic Functioning.

JAMA Psychiatry, 2023
Kessing LV, Ziersen SC, Caspi A, Moffitt TE, Andersen PK.   +4 more
europepmc   +1 more source

Psychotropic Drug Prescription in Nursing Homes During the COVID-19 Pandemic. [PDF]

Drugs Aging, 2022
Ferro Uriguen A, Laso Lucas E, Sannino Menicucci C, Iturrioz Arrechea I, Alaba Trueba J, Echevarría Orella E, Gil Goikouria J, Beobide Telleria I.   +7 more
europepmc   +1 more source

Detecting cannabis use reduction through biochemical verification of urinary cannabinoids: An aggregated analysis of cannabis use disorder treatment trials examining average reductions and individual cut‐points

Addiction, EarlyView.
Abstract Background and aims Currently, there is no data‐driven cannabis reduction metric using biochemical verification, which represents a significant gap in cannabis harm reduction research, treatment and policy. Using aggregated data from 7 cannabis use disorder treatment trials, the aims of this analysis were to 1) determine if decreases in self ...
Erin A. McClure, Brian Neelon, Rachel L. Tomko, Ashley Dowd, Kevin M. Gray, Aimee L. McRae‐Clark, Nathaniel Baker   +6 more
wiley   +1 more source

Unforeseen Side Effects: The Impact of Forcibly Medicating Criminal Defendants on Sixth Amendment Rights [PDF]

, 2006
Likavec, Brenda A.
core   +2 more sources

Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling

Addiction, Volume 120, Issue 4, Page 686-687, April 2025.
Rachel Lees Thorne, Tom P. Freeman
wiley   +1 more source

Varenicline for cannabis use disorder: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark, Kevin M. Gray, Nathaniel L. Baker, Brian J. Sherman, Bryan Tolliver, Jessica Burt, Alonzo Steplight, Elizabeth Chapman, Amanda Wagner   +8 more
wiley   +1 more source

Night-Time Exposure to Road, Railway, Aircraft, and Recreational Noise Is Associated with Hypnotic Psychotropic Drug Dispensing for Chronic Insomnia in the Paris Metropolitan Area. [PDF]

Int J Environ Res Public Health
Chauvineau M, Host S, Ndiaye K, Sineau M, Decourt V, Hellot M, Mietlicki F, Léger D.   +7 more
europepmc   +1 more source

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis. [PDF]

Mol Psychiatry, 2023
Sjaarda J, Delacrétaz A, Dubath C, Laaboub N, Piras M, Grosu C, Vandenberghe F, Crettol S, Ansermot N, Gamma F, Plessen KJ, von Gunten A, Conus P, Kutalik Z, Eap CB.   +14 more
europepmc   +1 more source

Addiction‐related problems in Japan: A regional perspective

Addiction, EarlyView.
Abstract Japan's addiction landscape appears paradoxical. The lifetime use of illicit drugs is among the lowest in Organisation for Economic Cooperation and Development countries, but harm from alcohol, tobacco, and gambling ranks among the world's highest.
Soichiro Ide, Yoko Nishitani, Masahiko Sumitani, Masabumi Minami, Tadashi Isa, Masako Iseki, Michiko Ohkura, Hitoshi Okamoto, Tetsuro Kikuchi, Yuko Sekino, Hidehiko Takahashi, Kenji Takeuchi, Atsumi Nitta, Takeshi Honjo, Hiroshi Matsumoto, Tsuyoshi Miyakawa, Toshiya Murai, Toshihiko Matsumoto, Kazuyuki Nakagome, Kazutaka Ikeda   +19 more
wiley   +1 more source